Trials / Conditions / Recurrent Solid Tumors
Recurrent Solid Tumors
7 registered clinical trials studyying Recurrent Solid Tumors — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | ZEN003694 Combined With Niraparib in Patients With Metastatic or Recurrent Solid Tumors NCT06161493 | Haider Mahdi | Phase 1 |
| Recruiting | A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combinati NCT06031441 | Genentech, Inc. | Phase 1 |
| Completed | TCR-engineered T Cells in Solid Tumors (ACTengine IMA201-101) NCT03247309 | Immatics US, Inc. | Phase 1 |
| Terminated | Safety and Pharmacokinetic Study of IT-141 in Monotherapy in Patients With Advanced Cancer NCT03096340 | Intezyne Technologies, Inc. | Phase 1 |
| Completed | ONO-4538 Phase I Study in Patients With Solid Tumor NCT02261285 | Ono Pharmaceutical Co., Ltd. | Phase 1 |
| Completed | ONO-4538 Phase I Study in Patients With Solid Tumor NCT02261298 | Ono Pharmaceutical Co., Ltd. | Phase 1 |
| Terminated | Peripheral Blood Stem Cell Transplant (PBSCT) in Children With High Risk or Recurrent Solid Tumors NCT00966498 | Emory University | N/A |